MediWound (MDWD) Other financing activities (2013 - 2025)
MediWound (MDWD) posted quarterly Other financing activities of $2.8 million for Q3 2025, up 364.33% year-over-year from $600000.0 in Q3 2024, and up 232.46% quarter-over-quarter from $838000.0 in Q2 2025.
MediWound (MDWD) Other financing activities (2013 - 2025) Analysis & Trends
MediWound's Other financing activities history runs 10 years deep, the most recent figure standing at $2.8 million for Q3 2025.
- In Q3 2025, Other financing activities rose 364.33% year-over-year to $2.8 million; the TTM figure through Sep 2025 stood at $4.2 million (up 249.09% YoY), while the FY2024 annual figure was $1.2 million, down 95.14% from the prior year.
- Other financing activities for Q3 2025 stood at $2.8 million, up from $838000.0 in the prior quarter.
- The five-year high for Other financing activities was $25.2 million in Q1 2023, with the low at -$248000.0 in Q2 2023.
- The 5-year median for Other financing activities is $549500.0 (2024), against an average of $4.0 million.
- The sharpest annual moves came in 2024 and 2025: Other financing activities tumbled 98.02% in 2024, then jumped 654.95% in 2025.
- MediWound's Other financing activities stood at $3000.0 in 2021, then surged by 347133.33% to $10.4 million in 2022, then tumbled by 102.38% to -$248000.0 in 2023, then soared by 341.94% to $600000.0 in 2024, then jumped by 364.33% to $2.8 million in 2025.
- Business Quant data shows MDWD's Other financing activities at $2.8 million in Q3 2025, $838000.0 in Q2 2025, and $600000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.79 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Mar 31, 2024 | 499,000.00 |
| Mar 31, 2024 | 499,000.00 |
| Jun 30, 2023 | -248,000.00 |
| Jun 30, 2023 | -248,000.00 |
| Mar 31, 2023 | 25.16 Mn |
| Mar 31, 2023 | 25.16 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -4,000.00 |